Premium
Prognosis in IgA nephropathy
Author(s) -
PACKHAM David
Publication year - 1997
Publication title -
nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 61
eISSN - 1440-1797
pISSN - 1320-5358
DOI - 10.1111/j.1440-1797.1997.tb00221.x
Subject(s) - medicine , nephropathy , glomerulonephritis , stage (stratigraphy) , intensive care medicine , end stage renal failure , clinical trial , kidney , hemodialysis , endocrinology , paleontology , biology , diabetes mellitus
Summary: IgA nephropathy it is now widely recognized as the most common glomerulonephritis causing end‐stage renal failure (ESRF) in many parts of the world. Large series of patients have been analysed in an attempt to identify prognostic clinical and histological features. Increasingly the importance of stage specific analysis of such factors has been reflected in the literature. Such analysis suggests that if therapeutic trials are to be conducted in an attempt to improve prognosis in IgA nephropathy these will need to be organized on a multicentre basis under the auspices of an international organization.